5 research outputs found
El Mercado Único. La Europa sin Fronteras Interiores: educación y formación para la CE. Universidad Politécnica de Madrid
Duración del vídeo: 1h 38min 05sCiclo de conferencias sobre el Mercado Único dentro de la Acción Institucional'93 celebrado en la Universidad Politécnica de Madrid y presidido por el Secretario de Estado para las CC.EE, D. Carlos Westendorp junto con el Rector de la Universidad Politécnica de Madrid D. Rafael Portaencasa
Additional file 1: Figure S1. of Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders
Standard curves for measurement of sAPPα and sAPPβ concentrations. Typical standard curves for sAPPα and sAPPβ obtained using the original method (A) and those obtained using our modified method (B) are shown. The modified method yielded apparent differences, including higher values of absorbance at 450 nm at lower concentrations and the requirement for a much shorter time for the TMB reaction than the original method. (TIFF 325 kb
Additional file 3: Figure S1. of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Distributions of molecular alterations according to histology in Cohort 1. Figure S2. Kaplan-Meier analysis for Group A cases stratified by 1p/19q status. Figure S3. Kaplan-Meier analyses for GBM cases in Cohorts 1 and 2. (PPTX 172Â kb
Additional file 1: of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Supplementary Information. (DOCX 141Â kb
Additional file 2: Table S1. of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Molecular and clinical characteristics of Cohort 1 (n = 758). Table S2. Molecular and clinical characteristics of GBM cohort (n = 453). Table S3. Univariate and multivariate Cox regression analyses for Group A (IDH mutated-TERT mutated) tumors in Cohort 1 (n = 155). Table S4. Univariate and multivariate Cox regression analyses for Group B (IDH mutated-TERT wild-type) tumors in Cohort 1 (n = 131). Table S5. Univariate and multivariate Cox regression analyses for Group C (IDH wild-type-TERT wild-type) tumors in Cohort 1 (n = 237). Table S6. Univariate and multivariate Cox regression analyses for Group D (IDH wild-type-TERT mutated) tumors in Cohort 1 (n = 235). Table S7. Univariate and multivariate Cox regression analyses for GBM in Cohort 1 (n = 260). Table S8. Univariate and multivariate Cox regression analyses for GBM in Cohort 2 (n = 193). Table S9. Background of combined GBM cohort stratified by TERT and MGMT status (n = 453). Table S10. Survival time and WHO grade in each molecular subgroup of Cohort 1 (n = 758). (XLSX 254 kb